Modeling hypertrophic cardiomyopathy: Mechanistic insights and pharmacological intervention

Mosqueira, Diogo, Smith, James ORCID:, Bhagwan, Jamie R. and Denning, Chris (2019) Modeling hypertrophic cardiomyopathy: Mechanistic insights and pharmacological intervention. Trends in Molecular Medicine, 25 (9). pp. 775-790. ISSN 1471-4914

[thumbnail of Published_Version]
PDF (Published_Version)
Available under License Creative Commons Attribution.

Download (3MB) | Preview


Hypertrophic cardiomyopathy (HCM) is a prevalent and complex cardiovascular disease where cardiac dysfunction often associates with mutations in sarcomeric genes. Various models based on tissue explants, isolated cardiomyocytes, skinned myofibrils, and purified actin/myosin preparations have uncovered disease hallmarks, enabling the development of putative therapeutics, with some reaching clinical trials. Newly developed human pluripotent stem cell (hPSC)-based models could be complementary by overcoming some of the inconsistencies of earlier systems, whilst challenging and/or clarifying previous findings. In this article we compare recent progress in unveiling multiple HCM mechanisms in different models, highlighting similarities and discrepancies. We explore how insight is facilitating the design of new HCM therapeutics, including those that regulate metabolism, contraction and heart rhythm, providing a future perspective for treatment of HCM.

Item Type: Article
Uncontrolled Keywords: sdg 3 - good health and well-being ,/dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_being
Faculty \ School: Faculty of Medicine and Health Sciences > Norwich Medical School
UEA Research Groups: Faculty of Medicine and Health Sciences > Research Groups > Cardiovascular and Metabolic Health
Related URLs:
Depositing User: LivePure Connector
Date Deposited: 18 Jul 2019 08:30
Last Modified: 22 Oct 2022 05:03
DOI: 10.1016/j.molmed.2019.06.005

Actions (login required)

View Item View Item